Filippo Moriggia
Geschäftsführer bei NEWRON PHARMACEUTICALS S.P.A.
Ursprung des Netzwerks ersten Grades von Filippo Moriggia
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Filippo Moriggia
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Saladax Biomedical, Inc.
Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | Miscellaneous Commercial Services | Sales & Marketing | |
REBUS HOLDINGS, INC. | Biotechnology | Director/Board Member | |
2941881 Canada, Inc.
2941881 Canada, Inc. Medical SpecialtiesHealth Technology 2941881 Canada, Inc. manufactures and supplies pelvic health and gastrointestinal equipment and consumables. The company was founded by Raymond George Yves Laborie in 1967 and is headquartered in Mississauga, Canada. | Medical Specialties | Chairman | |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member | |
KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman | |
University of Oxford | College/University | Doctorate Degree | |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member | |
Hunter-Fleming Ltd.
Hunter-Fleming Ltd. Pharmaceuticals: MajorHealth Technology Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BIOFRONTERA AG | Pharmaceuticals: Major | Director of Finance/CFO | |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chairman | |
ABLYNX | Biotechnology | Chairman | |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
University of Bocconi | College/University | Undergraduate Degree | |
University of Geneva | College/University | Graduate Degree | |
University of Milan | College/University | Undergraduate Degree Undergraduate Degree | |
University of Hagen | College/University | Graduate Degree | |
PricewaterhouseCoopers SpA
PricewaterhouseCoopers SpA Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers SpA is a company based in Milan, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Coopers & Lybrand SpA
Coopers & Lybrand SpA Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Coopers & Lybrand SpA is an Italian company. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Yamanouchi Nordic | Corporate Officer/Principal | ||
Scandinavian Medical Research | Founder | ||
Synthélabo Scandinavia A/S | Corporate Officer/Principal | ||
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Swedish Orphan Biovitrum International AB
Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum International AB develops, manufactures, and sells pharmaceutical products and drugs. It offers patients and partners an international network specializing in the development, marketing and distribution of orphan drugs. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
Pfizer ApS
Pfizer ApS Medical DistributorsDistribution Services Part of Pfizer Inc., Pfizer ApS is a Danish bio-pharmaceutical company. The company is based in Ballerup, Denmark. Pfizer is one of the world's leading bio-pharmaceutical companies. | Medical Distributors | Corporate Officer/Principal | |
ORPHAZYME A/S | Pharmaceuticals: Major | Chairman | |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Director/Board Member | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman | |
MipSalus ApS
MipSalus ApS Miscellaneous Commercial ServicesCommercial Services MipSalus ApS is a Danish company that conducts research and experimental development in the field of natural sciences and engineering. | Miscellaneous Commercial Services | Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Director/Board Member | |
Constantia Flexibles Group GmbH
Constantia Flexibles Group GmbH Containers/PackagingProcess Industries Constantia Flexibles Group GmbH manufactures and supplies flexible packaging and labels. The company was founded by Richard Teich and Ernest Teich in 1912 and is headquartered in Vienna, Austria. | Containers/Packaging | Director/Board Member | |
Newron Suisse SA | Chief Executive Officer | ||
ASCELIA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Innoventa Medica ApS | Chairman | ||
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
CMC Sweden AB | Director/Board Member | ||
Newron Pharmaceuticals US, Inc. | President Director/Board Member Director/Board Member | ||
Nikolaus & Claudius Lohmann | Director of Finance/CFO | ||
Early Clinical Development Consulting Ltd. | Director/Board Member |
Statistik
International
Schweden | 14 |
Dänemark | 11 |
Deutschland | 6 |
Italien | 6 |
Vereinigtes Königreich | 5 |
Sektoral
Health Technology | 23 |
Commercial Services | 7 |
Consumer Services | 6 |
Finance | 5 |
Process Industries | 3 |
Operativ
Director/Board Member | 75 |
Chairman | 27 |
Independent Dir/Board Member | 27 |
Corporate Officer/Principal | 25 |
President | 12 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Bo Jesper Hansen | 34 |
Joseph deBethizy | 29 |
Patrick J. Langlois | 23 |
Ulrich Köstlin | 14 |
Luca Benatti | 12 |
Stefan Weber | 9 |
Marco Caremi | 8 |
Ravi Anand | 7 |
Roberto Galli | 6 |
Robert Leslie Holland | 6 |
Dennis Dionne | 3 |
Laura Faravelli | 1 |
- Börse
- Insiders
- Filippo Moriggia
- Unternehmensverbindungen